McKesson, CD&R agree to buy Option Care Health for $32.05 a share in $5.8 billion deal
Bitget2026/10/06 12:03CD&R, McKesson, and Option Care Health agreed to acquire Option Care Health for USD 32.05 per share. Deal values Option Care Health at about USD 5.8 billion enterprise value. CD&R to hold about 51% at close; McKesson to invest about USD 1.4 billion for about 49%. Option Care Health expected to remain a separate company under its existing management team. Closing targeted for the first half of calendar 2027; Option Care Health shares to be delisted, making it privately held. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. McKesson Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20261005837505) on October 06, 2026, and is solely responsible for the information contained therein.
- CD&R, McKesson, and Option Care Health agreed to acquire Option Care Health for USD 32.05 per share.
- Deal values Option Care Health at about USD 5.8 billion enterprise value.
- CD&R to hold about 51% at close; McKesson to invest about USD 1.4 billion for about 49%.
- Option Care Health expected to remain a separate company under its existing management team.
- Closing targeted for the first half of calendar 2027; Option Care Health shares to be delisted, making it privately held.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Goldman Sachs dramatically lowers KOSPI target from 12,000 to 9,000 points, still insists there is 60% upside potential
Goldman Sachs strategists have lowered their 12-month target for South Korea's KOSPI Index from 12,000 points to 9,000 points, representing a 25% decrease. Earlier this year, Goldman had raised the target multiple times. The latest downgrade is due to mounting concerns in the market over artificial intelligence (AI) trading.

AI investment has not ended; wealth is simply being redistributed.


Can NEAR Protocol defend $4.30 support after a 10% price drop?